ACCESS Newswire

We are ACCESS Newswire, a globally trusted Public Relations (PR) and Investor Relations (IR) solutions provider. With a focus on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands to connect with their audiences where it matters most. From startups and scale-ups to multi-billion-dollar global brands, we ensure your most important moments make an impact and resonate with your audiences.
Results: 829-840 of 844

DynaResource, Inc. and DynaResource De México SA De CV. Announce Extension of Offtake Agreement With Ocean Partners Holdings Ltd.

INNIO Group Announces That Its Jenbacher Brand is a Winner of the COGEN Europe Recognition Award 2023 for Market Development

Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine

NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
